This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_KAPOSI_SARCOMA_EXALLC for full statistics.
Kaposi sarcoma
C3_KAPOSI_SARCOMA
Kaposi's sarcoma: A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
43
Check minimum number of events None
43
Include endpoints None
43
Remove individuals based on genotype QC
40
C3_KAPOSI_SARCOMA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C45-C49
Name in latin
Sarcoma Kaposi
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Kaposi sarcoma
based on the number of shared cases.
Broader endpoints:
- Kaposi sarcoma (controls excluding all cancers)
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 40 | 8 | 32 |
| Unadjusted prevalence (%) | 0.01 | 0.00 | 0.02 |
| Mean age at first event (years) | 66.85 | 65.46 | 67.19 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_KAPOSI_SARCOMA – Kaposi sarcoma
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Kaposi sarcoma
↥Endpoint not on priority list, no data to show.